- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Johnson & Johnson
Latest Johnson & Johnson Items
Subsidiaries of Johnson & Johnson have agreed to pay $5.9 million to settle a lawsuit with Montana over how an anti-psychotic drug was marketed, state Attorney General Tim Fox said Thursday.
The contractor working for New Jersey's largest utility at the site of a town house explosion that killed one resident recently had been fined more than $100,000 by safety regulators for problems at two other sites, but the utility said Wednesday it never had any problems with the construction firm.
A lawyer for two pharmaceutical companies argued Thursday that the Arkansas Supreme Court should reverse a $1.2 billion judgment because the trial judge improperly applied a law in the state's lawsuit over improper marketing of the antipsychotic drug Risperdal.
A federal judge has ruled in favor of a manufacturer in a lawsuit brought by a Texas woman who claimed her pelvic pain was caused by implanted surgical mesh.
The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.
Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains.
Indiana-based Biomet has agreed to pay a base rate of $200,000 each to hundreds of people who received artificial hips that were later replaced.
STRONG QUARTER: Johnson & Johnson's fourth-quarter net income jumped 19 percent to $3.52 billion. Revenue rose 4.5 percent to $18.36 billion.
Surging sales of Johnson & Johnson's prescription medicines and the rebound of its recall-plagued consumer health business lifted fourth-quarter profit 19 percent.